New trends of progestins treatment of endometriosis

References

• Locci R, Nisolle M, Angioni S, et al. Expression of the gamma 2 chain of laminin-332 in eutopic and ectopic endometrium of patients with endometriosis. Reprod Biol Endocrinol 2013;11:94
   PubMed Web of Science ®Google Scholar
• Jones CJ, Inuwa IM, Nardo LG, et al. Eutopic endometrium from women with endometriosis shows altered ultrastructure and glycosylation compared to that from healthy controls – a pilot observational study. Reprod Sci 2009;16:559–72
   PubMed Web of Science ®Google Scholar
• Melis I, Agus M, Pluchino N, et al. Alexithymia in women with deep endometriosis? A pilot study. J Endometriosis Pelvic Pain Dis 2014;6:26–33
   Google Scholar
• Melis GB, Guerriero S, Paoletti AM, et al. Diagnosis of endometriosis. Giornale Italiano di Ginecologia e Ostetricia 2005; 27:293–6
   Google Scholar
• Socolov R, Butureanu S, Angioni S, et al. The value of serological markers in the diagnosis and prognosis of endometriosis: a prospective case-control study. Eur J Obstet Gynecol Reprod Biol 2011;154:215–17
   PubMed Web of Science ®Google Scholar
• Angioni S, Peiretti M, Zirone M, et al. Laparoscopic excision of posterior vaginal fornix in the treatment of patients with deep endometriosis without bowel involvement: surgical treatment and long term follow-up. Hum Reprod 2006;21:1629–34
   PubMed Web of Science ®Google Scholar
• Angioni S, Maricosu G, Mereu L, et al. Single Port Access Laparoscopy (SPAL) for endometrioma excision. J Endometriosis Pelvic Pain Dis 2010;2:95–8
   Google Scholar
• Pisanu A, Deplano D, Angioni S, et al. Rectal perforation from endometriosis in pregnancy: case report and literature review. World J Gastroenterol 2010;16:648–51
   PubMed Web of Science ®Google Scholar
• Rizzo A, Spedicato M, Mutinati M, et al. Peritoneal adhesions in human and veterinary medicine: from pathogenesis to therapy: a review. Immunopharmacol Immunotoxicol 2010;32:481–94
   PubMed Web of Science ®Google Scholar
• Litta, P, D'Agostino G, Conte L, et al. Müllerian hormone trend after laparoscopic surgery in women with ovarian endometrioma. Gynecol Endocrinol 2013;29:452–4
   PubMed Web of Science ®Google Scholar
• Vercellini P, Fedele L, Aimi G, et al. Reproductive performance, pain recurrenceand disease relapse after conservative surgical treatment for endometriosis: the predictive value of current system. Hum Reprod 2006;21:2679–85
   PubMed Web of Science ®Google Scholar
• Vercellini P, De Giorgi O, Mosconi P, et al. Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis. Fertil Steril 2002; 77:52–61
   PubMed Web of Science ®Google Scholar
• Muneyyirci -Delale O, Karacan M. Effect of norethindrone acetate in the treatment of symptomatic endometriosis. Int J Fertil Women Med 1998;43:24–7
   PubMedGoogle Scholar
• Harrison RF, Barry-Kinsella C. Efficacy of medroxyprogesterone treatment in infertile women with endometriosis: a prospective, randomized, placebo-controlled study. Fertil Steril 2000;74:24–30
   PubMed Web of Science ®Google Scholar
• Gomes MK, Rosa e Silva JC. Effects of the levonorgestrel-releasing intrauterine system on cell proliferation, Fas expression and steroid receptors in endometriosis lesions and normal endometrium. Hum Reprod 2009;24:2736–745
   PubMed Web of Science ®Google Scholar
• Abou-Setta AM, Houston B, Al-Inany HG, et al. Levonorgestrel-releasing intrauterine device (LNG – IUD) for symptomatic endometriosis following surgery. Cochrane Database Syst Rev 2013;1:CD005072
   Google Scholar
• Lockhat FB, Emembolu JO, Konje JC. The evaluation of the effectiveness of an intrauterine-administrated progestogen (levonorgestrel) in the symptomatic treatment of endometriosis and in the staging of disease. Hum Reprod 2004;1:179–84
   Google Scholar
• Lockhat FB, Emembolu JO, Konje JC. The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up. Hum Reprod 2005;20:789–93
   PubMed Web of Science ®Google Scholar
• Petta CA, Ferriani RA, Abrao MS, et al. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis. Hum Reprod 2005;20:1993–8
   PubMed Web of Science ®Google Scholar
• Vercellini P, Frontino G, De Giorgi O, et al. Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study. Fertil Steril 2003;80:305–9
   PubMed Web of Science ®Google Scholar
• Lan S, Ling L, Zhao J, et al. Analysis of the levonorgestrel-releasing intrauterine system in women with endometriosis. J Inte Med Res 2013; 41:548–58
   PubMed Web of Science ®Google Scholar
• Fedele L, Bianchi S, Zanconato G, et al. Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis. Fertil Steril 2001;75:485–8
   PubMed Web of Science ®Google Scholar
• Wenzl R, van Beek A, Schnabel P, et al. Pharmacogenetics of etonogestrel released from the contraceptive implant Implanon. Contraception 1998;58:283–8
   PubMed Web of Science ®Google Scholar
• Walch K, Unfried G, Huber J, et al. Implanon versus medroxyprogesterone acetate: effects on pain scores in patients with symptomatic endometriosis – a pilot study. Contraception 2009;79:29–34
   PubMed Web of Science ®Google Scholar
• Affandi B. An integrated analysis of vaginal bleeding patterns in clinical trials of Implanon. Contraception 1998;58:99S–107S
   PubMed Web of Science ®Google Scholar
• Xiangyan R, Seeger H, Mueck AO. The pharmacology of dienogest. Maturitas 2012;71:337–44
   PubMed Web of Science ®Google Scholar
• Oettel M, Graser T, Hoffman H. Why dienogest as a progestogenic component of the postmenopausal nonandrogenic hormone replacement therapy. Drugs Today 2001;37:3–15
   Web of Science ®Google Scholar
• Kohler G, Faustmann TA, Gerlinger C, et al. A dose ranging study to determine the efficacy and safety of 1, 2 and 4 mg of dienogest daily for endometriosis. Int J Gynaecol Obstet 2010;108:21–5
   PubMed Web of Science ®Google Scholar
• Momoeda M, Taketani Y. A randomized, double-blind, multicenter, parallelel, dose-response study of dienogest in patients with endometriosis [article in Japanese]. J Pharmacol Ther 2007;35:769–83
   Google Scholar
• Strowitzki T, Faustmann T, Gerlinger C, et al. Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study. Eur J Obstet Gynaecol Reprod Biol 2010;151:193–8
   PubMed Web of Science ®Google Scholar
• Petraglia F, Hornung D, Seitz C, et al. Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment. Arch Gynecol Obstet 2012; 285:167–73
   PubMed Web of Science ®Google Scholar
• Strowitzki T, Marr J, Gerlinger C, et al. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Hum Reprod 2010;25:633–41
   PubMed Web of Science ®Google Scholar
• Harada T, Momoeda M, Taketani Y, et al. Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis: a randomized, double-blind, multicenter, controlled trial. Fertil Steril 2009;91:675–81
   PubMed Web of Science ®Google Scholar
• Cosson M, Queleu D, Donnez J, et al. Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study. Fertil Steril 2002;77:684–92
   PubMed Web of Science ®Google Scholar
• Schindler AE, Henkel A, Moore C, et al. Effect and safety of high dose dienogest (20 mg/day) in the treatment of women with endometriosis. Arch Gynecol Obstet 2010;282:507–14
   PubMed Web of Science ®Google Scholar
• Artini PG, Volpe A, Angioni S, et al. A comparative randomized study of three different progesterone support of the luteal phase following IVF/ET program. J Endocrinol Invest 1995;18:57–62
   PubMed Web of Science ®Google Scholar
• Florio P, Imperatore A, Litta P, et al. The use of nomegestrol acetate in rapid preparation of endometrium before operative hysteroscopy in pre-menopausal women. Steroids 2010;75:912–17
   PubMed Web of Science ®Google Scholar
• Pluchino N, Cubeddu A, Giannini A, et al. Progestogens and brain: an update. Maturitas 2009;62:349–55
   PubMed Web of Science ®Google Scholar